Inventor
YUNSHENG HE
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms31%
A61KPreparations for medical, dental or toiletry purposes23%
C07KPeptides15%
PatentTitleYear
12,215,387Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment202512,146,187Methods of treating dry eye disease using TNF alpha antagonists202411,725,246Methods of treating ophthalmic disorders202311,359,241Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to NOVARTIS AG (4)· patent assignee history
2022–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVARTIS AG | 4 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2022–2025 |